Yahoovia Finnhub
As investors wait for the Claude developer to file its official IPO paperwork, several biotechs are going public and doing just fine.
Yahoovia Finnhub
CAMBRIDGE, Mass., Oct. 19, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (Nasdaq: CTY) (“City” or “City Therapeutics”), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics, today announced the closing of its upsized…
Yahoovia Finnhub
City Therapeutics (CTY) has moved quickly after its Nasdaq launch, pairing a roughly $200 million IPO with a fresh $239.1 million shelf registration tied to 13.3 million ESOP related common shares. For readers tracking the trading action, City Therapeutics has seen a 1 day share…
Yahoovia Finnhub
City Therapeutics (NasdaqGM: CTY) has completed its initial public offering and is now trading on the public markets. Shortly after the IPO, the business filed a large shelf registration statement that could support future equity issuance. The shelf filing may give City…
SeekingAlphavia Finnhub
No IPOs are currently scheduled for the week ahead as the yearâs next mega IPO potentially comes into view. Read more here.